Glycophospholipid formulation with NADH and CoQ10 significantly reduces intractable fatigue in western blot-positive 'chronic lyme disease' patients: Preliminary report

Functional Foods in Health and Disease

Volumn 2, Issue 3, 2012, Pages 35-47

  Nicolson, Garth L ^a   Settineri, Robert ^b   Ellithorpe, Rita ^c  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b Sierra Productions Research LLC   (United States)

^c Tustin Longevity Center   (United States)

Author keywords

Chronic fatigue; Coenzyme Q10; Lipid Replacement Therapy; Lyme disease; Mitochondria; NADH; NT Factor

Indexed keywords

EID: 84899449753     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v2i3.100     Document Type: Article

References (61)

1. Depietropaolo DL, Powers JH, Gill JM, Foy AJ. Diagnosis of Lyme disease. Am Family Physician 2005; 72: 297-309.
2. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 1994; 21(3): 454-461.
3. Stricker RB, Laufin A, Burrascano JJ. Lyme disease: point/counterpoint. Expert Rev Anti-infect Ther 2005; 3(2): 155-165.
4. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme syndrome. Curr Opin Rheumatol 2002; 4(4): 383-387.
5. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 2005; 34(6): 1340-1345.
6. Shor S. Lyme Disease presenting as Chronic Fatigue Syndrome. J Chronic Fatigue Syndr 2006; 13(4): 67-75.
7. Nicolson GL, Nicolson NL, Haier J. Chronic Fatigue Syndrome patients subsequently diagnosed with Lyme Disease Borrelia burgdorferi: evidence for Mycoplasma species co-infections. J Chronic Fatigue Syndr 2008; 14(4): 5-17.
8. Chia JKS, Chia LY. Chronic Chlamydia pneumoniae infection: a treatable cause of Chronic Fatigue Syndrome. Clin Infect Dis 1999; 29: 452-453.
9. Nicolson GL, Nasralla M, Gan R, Haier J, De Meirleir K. Evidence for bacterial (Mycoplasma, Chlamydia) and viral (HHV-6) co-infections in chronic fatigue syndrome patients. J Chronic Fatigue Syndr 2003; 11(2): 7-20.
10. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. High prevalence of mycoplasmal infections among European Chronic Fatigue Syndrome patients. Examination of four Mycoplasma species in Chronic Fatigue Syndrome patients. FEMS Immunol Med Microbiol 2002; 34: 209-214.
11. Chambers D, Bagnall A-M, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encepthalomyelitis: an updated systematic review. J Royal Soc Med 2006; 99: 506-520.
12. Reid S, Chalder T, Cleare Hotopf AM, Wessley S. Chronic fatigue syndrome. Clin Evid 2011; 2011: 1101.
13. Morrison JD. Fatigue as a presenting complaint in family practice. J Family Pract 1980; 10: 795-801.
14. Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-934.
15. Purvis D, Gonsalves S, Deuster PA. Physiological and psychological fatigue in extreme conditions: overtraining and elite athletes. Phys Med Rehabil 2010; 2: 442-450.
16. Nicolson GL, Settineri R. Lipid Replacement Therapy: a functional food approach with new formulations for reducing cellular oxidative damage, cancer-associated fatigue and the adverse effects of cancer therapy. Funct Food Health Dis 2011; 4: 135-160.
17. Knicker AJ, Renshaw I, Oldham AR, Cairns SP. Interactive processes link the multiple symptoms of fatigue in sports competition. Sports Med 2011; 41: 307-328.
18. Brand MD, Nicholis DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435: 297-312.
19. Duchen MR, Szabadkai G. Roles of mitochondria in human disease. Essays Biochem 2010; 47: 115-137.
20. Halliwell B. Oxidative stress, nutrition and health. Free Rad Res 1996; 25: 57-74.
21. Montero J, Mari M, Colell A, Morales A, Basanez G, Garcia-Ruiz C, Fernandez-Checa JC. Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and death. Biochim Biochys Acta 2010; 797: 1217-1224.
22. Nicolson GL. Lipid replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function. J Am Nutraceut Assoc 2003; 6(3): 22-28.
23. Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010; 12: 125-169.
24. Kanno T, Sato EE, Muranaka Fujita SH, Fujiwara T, Utsumi T, Inoue M, Utsumi K. Oxidative stress underlies the mechanism for Ca(2+)-induced permeability transition of mitochondria. Free Rad Res 2004; 38(1): 27-35.
25. Stadtman E. Introduction to serial reviews on oxidatively modified proteins in aging and disease. Free Rad Biol Med 2002; 32: 789.
26. Castro L, Freeman BA. Reactive oxygen species in human health and disease. Nutr 2001; 17: 295-307.
27. Huang JH, Hood DA. Age-associated mitochondrial dysfunction in skeletal muscle: contributing factors and suggestions for long-term interventions. IUBMB Life 2009; 61: 201-214.
28. Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004; 54(Suppl 1): S110-S118.
29. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010; 345: 91-104.
30. Nicolson GL, Ellithrope RR. Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses. J Chronic Fatigue Syndr 2006; 13(1): 57-68.
31. Piper BF, Linsey AM, Dodd MJ. Fatigue mechanism in cancer. Oncol Nurs Forum 1987; 14: 17-23.
32. Piper BF, Dribble SL, Dodd MJ. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998; 25: 667-684.
33. Bland JM, Altman DG. Statistical notes: Cronbach‟s alpha. Brit Med J 1997; 314: 572.
34. Burrascano Jr JJ. Advanced topics in Lyme disease: diagnostic hints and treatment guidelines for Lyme and other tick-borne illnesses, 16th ed., Bethesda: Intern Lyme Assoc Dis Soc, 2008, pp. 1-37.
35. Ellithorpe RR, Settineri R, Nicolson GL. Reduction of fatigue by use of a dietary supplement containing glycophospholipids. J Am Nutraceut Assoc 2003; 6(1): 23-28.
36. Nicolson GL, Ellithorpe RR, Ayson-Mitchell C, Jacques B, Settineri R. Lipid Replacement Therapy with a glycophospholipid-antioxidant-vitamin formulation significantly reduces fatigue within one week. J Am Nutraceut Assoc 2010; 13(1): 11-15.
37. Stricker, RB, Johnson L. Lyme disease: the next decade. Infect Drug Resist 2011; 4: 1-9.
38. Steere, AC. Lyme disease: a growing threat to urban populations. Proc Nat Acad Sci USA 1994; 91: 2378-2383.
39. Vojdani A, Hebroni F, Raphael Y, Erde J, Raxien B. Novel diagnosis of Lyme Disease: potential for CAM intervention. Evid Based Complement Alternat Med 2009; 6(3): 283-295.
40. Taylor RS, Simpson IN. Review of treatment options for Lyme borreliosis. J Chemother 2005; 17(Suppl 2): 3-16.
41. Bock SJ. The integrative treatment of Lyme disease. Int J Integ Med 1999; 1: 19-23.
42. Nicolson GL. Diagnosis and therapy of chronic systemic co-infections in Lyme disease and other tick-borne infections. Townsend Lett 2007; 285: 93-98.
43. Agadjanyan M, Vasilevko V, Ghochikyan A, Berns P, Kesslak P, Settineri R, Nicolson GL. Nutritional supplement (NTFactor) restores mitochondrial function and reduces moderately severe fatigue in aged subjects. J Chronic Fatigue Syndr 2003; 11(3): 23-36.
44. Seidman M, Khan MJ, Tang WX, Quirk WS. Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 2002; 127: 138-144.
45. Forsyth LM, Preuss HG, MacDowell AL, Chiazze Jr L, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 1999; 82: 185-191.
46. Colquhoun D, Senn S. Is NADH effective in the treatment of chronic fatigue syndrome? Ann Allergy Asthma Immunol 2000; 84: 639-640.
47. Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J Royal Soc Med 2006; 99: 506-520.
48. Santaella ML, Font I, Disdier OM. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome. Puerto Rico Health Sci J 2004; 23(2): 89-93.
49. Alegre J, Rosés JM, Javierre C, Ruiz-Baqués A, Segundo MJ, de Sevilla TF. Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome. Rev Clin España 2010; 210(6): 284-288.
50. Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends Biochem Sci 2007; 32: 12-19.
51. Chen L, Petrelli R, Felczak K, Gao G, Bonnac L, Yu YS, Bennett EM, Pankiewicz KW. Nicotinamide adenine dinucleotide based therapeutics. Curr Medicin Chem 2008; 15(7): 650-670.
52. Ying W. NAD+ and NADH in cellular functions and death. Front Biosci 2006; 11: 3129-3148.
53. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Medicin Chem 2010; 17: 4256-4269.
54. Quinzii CM, Hirano H. Coenzyme Q and mitochondrial disease. Develop Disabil Res Rev 2010; 16: 183-188.
55. Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutr 2010; 26: 250-254.
56. Orsucci D, Filosto M, Siciliano G, Mancuso M. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Nutr Rev 2009; 67: 427-438.
57. Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targ 2010; 11: 111-121.
58. Tarnopolsky MA. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 2008; 60: 1561-1567.
59. Beg S, Javed S, Kohli K. Bioavailability enhacement of coenzyme Q10: an extensive review of patents. Rec Patents Drug Deliv Formul 2010; 4(3): 245-255.
60. Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Intern J Clin Exp Med 2009; 2(1): 1-16.
61. Cameron DJ. Proof that chronic Lyme disease exists. Interdisc Perspect Infect Dis 2010; 1-4, doi:10.1155/2010/876450.